Pancreatic Cancer Research

ResearcherInstituto Murciano de Investigación BiosanitariaActive in the last 2 years

Víctor López‐López

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1718-3352; OpenAlex author ID A5020723600. Sources: OpenAlex.

Their work

Papers
5 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
53
Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: 1 paper · 2026: 3 papers

Papers 5

  1. Benefit of adjuvant chemotherapy for resected pancreatic cancer following neoadjuvant FOLFIRINOX or Gemcitabine-Nab-paclitaxel: a multinational analysis. Co-author DOI 10.1093/jnci/djag235↗
  2. Benefit of Adjuvant Therapy After Neoadjuvant Therapy and Resection for Patients with Pancreatic Cancer: A Systematic Review and Meta-analysis. First author DOI 10.1245/s10434-026-19841-5↗
  3. ASO Visual Abstract: Benefit of Adjuvant Therapy after Neoadjuvant Therapy and Resection for Patients with Pancreatic Cancer: A Systematic Review and Meta-anal… First author DOI 10.1245/s10434-026-19926-1↗
  4. Surgical treatment of liver metastasis from pancreatic cancer. Co-author DOI 10.1016/j.suronc.2025.102308↗
  5. FOLFIRINOX or Gemcitabine-based Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: A Multi-institutional, Patient-Level, Meta-analy… Co-author DOI 10.1245/s10434-023-13353-2↗

Closest collaborators

The 25 strongest of 53 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Dilmurodjon Eshmuminov · 4 shared papers, 2023–2026 · strength 0.81
  2. Changhoon Yoo · 4 shared papers, 2023–2026 · strength 0.81
  3. José Oberholzer · 3 shared papers, 2026 · strength 0.69
  4. Ning Pu · 3 shared papers, 2026 · strength 0.69
  5. Michael C. Frey · 3 shared papers, 2026 · strength 0.69
  6. So Heun Lee · 3 shared papers, 2026 · strength 0.69
  7. Ralph Fritsch · 3 shared papers, 2026 · strength 0.69
  8. Bradley Norman Reames · 2 shared papers, 2026 · strength 0.50
  9. Haleh Amirian · 2 shared papers, 2026 · strength 0.50
  10. Chunmeng Zhang · 2 shared papers, 2026 · strength 0.50
  11. Jashodeep Datta · 2 shared papers, 2026 · strength 0.50
  12. Giuseppe Malleo · 2 shared papers, 2023–2026 · strength 0.31
  13. Gregory C. Wilson · 2 shared papers, 2023–2026 · strength 0.31
  14. Ryan K. Schmocker · 2 shared papers, 2023–2026 · strength 0.31
  15. Jin Peng He · 2 shared papers, 2023–2026 · strength 0.31
  16. Russell F. Palm · 2 shared papers, 2023–2026 · strength 0.31
  17. Elena B. Rangelova · 2 shared papers, 2023–2026 · strength 0.31
  18. Sarah E. Hoffe · 2 shared papers, 2023–2026 · strength 0.31
  19. Sameer H. Patel · 2 shared papers, 2023–2026 · strength 0.31
  20. Syed A. Ahmad · 1 shared paper, 2026 · strength 0.19
  21. Liang Liu · 1 shared paper, 2026 · strength 0.19
  22. Patricia Sánchez‐Velázquez · 1 shared paper, 2026 · strength 0.19
  23. Benedetto Ielpo · 1 shared paper, 2026 · strength 0.19
  24. Gabriella Lionetto Lionetto · 1 shared paper, 2026 · strength 0.19
  25. Timothy Michael Pawlik · 1 shared paper, 2026 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.